Inhibition of protein tyrosine phosphatase 1B by serratane triterpenes from Huperzia serrata and their molecular docking study

  • Bioorg Med Chem Lett. 2024 Oct 1:111:129904. doi: 10.1016/j.bmcl.2024.129904.
Byeol Ryu  1 Jorge-Eduardo Ponce-Zea  1 Van-Hieu Mai  1 Mina Lee  2 Sang Hyun Sung  1 Young Won Chin  1 Won Keun Oh  3
Affiliations
  • 1. Korea Bioactive Natural Material Bank, Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 151-742, Republic of Korea.
  • 2. College of Pharmacy, Research Institute of Life and Pharmaceutical Sciences, Sunchon National University, 255 Jungangno, Suncheon 57922, Jeonnam, Republic of Korea.
  • 3. Korea Bioactive Natural Material Bank, Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 151-742, Republic of Korea. Electronic address: [email protected].
Abstract

During the search for protein tyrosine Phosphatase 1B (PTP1B) inhibitory compounds from the natural resources, two new serratane Triterpenes, 3-O-dihydro-p-coumaroyltohogenol (1) and 21-O-acetyltohogenol (2), along with four known serratane Triterpenes (3-6), were isolated from the whole plant of Huperzia serrata. The chemical structures of compounds 1 and 2 were determined by NMR study, HRMS analysis, and chemical modification. All isolates were evaluated for their PTP1B inhibitory activities. Among the isolates, compounds 1, 3, 5 and 6 exhibit moderate inhibitory activities against PTP1B. Kinetic studies demonstrated that they are competitive inhibitors. Molecular docking studies support these experimental results by showing that compounds 1, 3, 5 and 6 interact with the active site of PTP1B, clarifying the structure-activity relationship. This study suggests that serratane Triterpenes from H. serrata have potential as starting skeletons for anti-diabetes or anti-obesity agents.

Keywords
Huperzia serrata; Molecular docking study; Protein tyrosine phosphatase 1B; Serratane triterpenes.
Products